Queensland government-supported plasma biotech Aegros is attempting to raise $20 million from investors ahead of a 2025 float, despite one of its suppliers being forced to lodge a winding up action in the Supreme Court of Victoria to secure payment.
The business, co-founded by haematologist Hari Nair and biotech entrepreneur John Manusu in 2017, is attempting to commercialise a blood plasma fractionation technology that has been in development since the 1980s and is designed to provide a major boost to the yield of immunoglobulin from plasma.
Loading...
Yolanda Redrup is the editor of the AFR Rich List. She previously reported on technology, healthcare and Street Talk. Connect with Yolanda on Twitter. Email Yolanda at yolanda.redrup@afr.com
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
